Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Conus peptides and neuroprotection.

Christine E Heading1

  • 1Department of Biological Sciences, The Open University, Milton Keynes, UK. moore11@globalnet.co.uk

Current Opinion in Investigational Drugs (London, England : 2000)
|July 26, 2002
PubMed
Summary

Conus peptides show neuroprotective potential by targeting NMDA receptors or potassium channels, offering hope for neurological conditions. However, their poor pharmacokinetic profiles present a significant challenge for therapeutic development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gender issues and the pharmacotherapy of substance abuse.

IDrugs : the investigational drugs journal·2008
Same author

Drug evaluation: CYT-002-NicQb, a therapeutic vaccine for the treatment of nicotine addiction.

Current opinion in investigational drugs (London, England : 2000)·2007
Same author

Vivitrex (Alkermes/Cephalon).

Current opinion in investigational drugs (London, England : 2000)·2006
Same author

Conus toxins: targets and properties.

IDrugs : the investigational drugs journal·2004
Same author

NicVAX (Nabi Biopharmaceuticals).

IDrugs : the investigational drugs journal·2003
Same author

Recent advances against substance abuse.

IDrugs : the investigational drugs journal·2003

Area of Science:

  • Neuroscience and Pharmacology
  • Peptide Therapeutics

Background:

  • Conus peptides are a diverse group of bioactive molecules with various biological targets.
  • Over 50,000 Conus peptides are estimated to exist, with several showing potential neuroprotective properties.

Purpose of the Study:

  • To review the neuroprotective potential of Conus peptides.
  • To assess the therapeutic viability of Conus peptides targeting different neurological pathways.

Main Methods:

  • Literature review of Conus peptide research.
  • Analysis of peptide activity at voltage-gated calcium channels, NMDA receptors, nicotinic receptors, and potassium channels.

Main Results:

  • Conus peptides targeting NMDA receptors show promise for acute and chronic neuroprotection.
  • Peptides acting on nicotinic receptors or potassium channels may offer potential against chronic neurological assault.
  • The efficacy of Conus peptides blocking voltage-gated calcium channels is currently uncertain.

Conclusions:

  • Conus peptides represent a promising class of neuroprotective agents, particularly those acting on NMDA receptors.
  • Targeting specific receptors offers distinct therapeutic avenues for acute and chronic neurological conditions.
  • Improving the pharmacokinetic profile of Conus peptides is crucial for their clinical application.

Related Experiment Videos